beta
Trial Radar AI
I can help you find nearby clinical trials and understand health conditions and treatments.
198 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Keywords
Overweight
×
 
Study Type
Interventional
×
 
Intervention
GLP-1
×
 
Study Title
Status
Effects of GLP-1 Formula on GLP-1 and Glucose Regulation NCT07082062
Recruiting
Impact GLP-1 Agonists Following Bariatric NCT06132477
Recruiting
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery (Maigrir_OT) NCT06278285
Recruiting
Effects of a GLP-1 Formula Drink on Gut Microbiota and Glycemic Control in Prediabetic Individuals NCT07089732
Not yet recruiting
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity) NCT07480109
Not yet recruiting
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528
Not yet recruiting
Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment (MYO-PRESERVE) NCT07393360
Recruiting
Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions (COMO-1) NCT06867718
Active, not recruiting
Stanford Pediatric Healthy Weight Index NCT07316816
Recruiting
Effect of GLP-1 Receptor Agonists on Body Composition in Obesity: The Role of Dietary Protein Consumption in Muscle Mass Maintenance (LEAN-PRO GLP-1) NCT07495904
Recruiting
MAINTAIN (Mucosal AblatIoN Therapy After INcretins) NCT06734312
Recruiting
Effect of Supplement on Appetite and GLP-1 (GLP-1 Suppleme) NCT06790771
Not yet recruiting
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness NCT06487832
Recruiting
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight (VESPER-1) NCT06712836
Active, not recruiting
A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults (SOLUTION-Pilot) NCT07364175
Recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery (GEM-GLP1RA) NCT07100691
Not yet recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer NCT06751589
Recruiting
Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment (PROBIO-GLP1) NCT07213323
Not yet recruiting
Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss. (OBA) NCT07411378
Not yet recruiting
Strength Training Response of Muscle in GLP-1 Users (STRONG-GLP) NCT07104539
Recruiting
A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health NCT06911073
Recruiting
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH NCT06410924
Active, not recruiting
GLP-1R Actions on Muscle and the Skeleton (GRAMS) NCT07154719
Not yet recruiting
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis (COMBAT-PsA) NCT07443956
Not yet recruiting
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese NCT06732245
Not yet recruiting
A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (BMT-801) NCT06565611
Active, not recruiting
Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity (SEMAMOOD) NCT07136714
Recruiting
Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants NCT07223216
Recruiting
Physical Inactivity and Appetite Regulation NCT06240208
Recruiting
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity NCT07091500
Recruiting
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment NCT06411210
Recruiting
A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial) NCT06605703
Active, not recruiting
Gut Hormones and Roux en Y Gastric Bypass NCT01945840
Recruiting
Activity of Bioactive Natural Compounds as Potential Agonists of GLP1R (BIOBESICOM) NCT06513715
Active, not recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) NCT07104383
Recruiting
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity NCT06775093
Not yet recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US NCT07431086
Recruiting
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults NCT06827002
Active, not recruiting
VK2735 for Weight Management Phase 3 (VANQUISH 1) NCT07104500
Active, not recruiting
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy NCT07244445
Recruiting
Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment (FLEX) NCT07457437
Recruiting
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions NCT06801015
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Overweight/Obese Subjects (DA168) NCT06953063
Active, not recruiting
Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide (REMAIN-1) NCT06484114
Active, not recruiting
Tirzepatide for Alcohol Use Disorder NCT06994338
Recruiting
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight (VESPER-3) NCT06973720
Active, not recruiting
Bariatric Surgery Combined With GLP-1 Receptor Agonists Study (BS-GLP) NCT07336862
Recruiting
GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease NCT06546384
Not yet recruiting